Liminatus Pharma Inc (LIMN) concluded trading on Thursday at a closing price of $8.47, with 11.37 million shares of worth about $96.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.18% during that period and on July 24, 2025 the price saw a gain of about 30.91%. Currently the company’s common shares owned by public are about 26.01M shares, out of which, 3.10M shares are available for trading.
Stock saw a price change of 54.84% in past 5 days and over the past one month there was a price change of -68.24%. Year-to-date (YTD), LIMN shares are showing a performance of -18.87% which decreased to -24.51% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.40 but also hit the highest price of $33.66 during that period. The average intraday trading volume for Liminatus Pharma Inc shares is 362.24K. The stock is currently trading 11.30% above its 20-day simple moving average (SMA20), while that difference is down -18.20% for SMA50 and it goes to -18.61% lower than SMA200.
Liminatus Pharma Inc (NASDAQ: LIMN) currently have 26.01M outstanding shares and institutions hold larger chunk of about 1.75% of that.
The stock has a current market capitalization of $220.34M and its 3Y-monthly beta is at 0.51. It has posted earnings per share of -$0.29 in the same period. It has Quick Ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LIMN, volatility over the week remained 18.10% while standing at 26.98% over the month.
